- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05443048
Evaluation of Monolithic Milled Complete Removable Dentures
The use of complete removable dental prostheses (CRDP) is a reliable and effective treatment option for the rehabilitation of edentulous persons.
In recent years, the use of computer-aided design/computer-aided manufacturing (CAD/CAM) methods has become more popular for the fabrication of CRDPs, including subtractive methods (milling) from a prefabricated resin puck. They present various advantages compared to conventional fabrication methods, namely improved mechanical properties, superior surface characteristics, shortened manufacturing time and lower cost for the patient.
However, one of the shortcomings in the manufacturing of CRDPs from a single block of resin is obtaining an adequate esthetic outcome, as the transition between the gingiva-colored (pink) and tooth-colored (white) resin is not as precise as with prefabricated prosthetic teeth which are incorporated into a denture base. A novel technology has recently been launched on the market and includes a new design of distribution of pink and white resin inside a prefabricated resin puck, which would allow a superior esthetic outcome than previous techniques.
The aim of this pilot study is to assess the end result of one of the available systems used for fabricating digital dentures (Ivoclar® Digital Denture®), while using the corresponding monolithic resin puck (Ivoclar® Ivotion Denture System®), and therefore determining whether this new technique is an adequate option for treating edentulous patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
GE
-
Genève, GE, Switzerland, 1211
- University of Geneva
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥ 18 years
- Informed Consent as documented by signature
- Healed edentulous maxilla and mandible (minimum one year since last extraction)
Exclusion Criteria:
- Contraindications to the medical devices used, e.g. known hypersensitivity or allergy
- Vulnerable subjects
- Known or suspected non-compliance, drug or alcohol abuse
- Inability to follow the procedures of the investigation
- Participation in another investigation with a MD in the field of dentistry
- Enrolment of the investigator, his/her family members, employees and other dependent persons
- Reported severe bruxism or clenching habits, clinically present oro-facial pain
- Width of edentulous maxilla > 80 mm
- Width of edentulous mandible > 80 mm
- Vertical height needed for maxillary prosthesis > 38 mm
- Vertical height needed for mandibular prosthesis > 38 mm
- Depression: Geriatric Depression Scale > 9
- Xerostomia: SSFR ≤ 0.7ml/min
- Dementia: Clock-Drawing Test ≤ 5
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Ivoclar Ivotion Denture System
|
Fabrication of maxillary and mandibular complete removable dental prosthesis with the Ivoclar Ivotion Denture System
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Esthetics
Time Frame: Baseline (BL, with existing dentures)
|
The transition between the pink and white resin will be evaluated by means of a Visual Analogue Scale esthetic score Maximum (best outcome): 1000 Minimum (worst outcome): 0
|
Baseline (BL, with existing dentures)
|
|
Esthetics
Time Frame: Day 0 (T0, new dentures)
|
The transition between the pink and white resin will be evaluated by means of a Visual Analogue Scale esthetic score Maximum (best outcome): 1000 Minimum (worst outcome): 0
|
Day 0 (T0, new dentures)
|
|
Esthetics
Time Frame: 3 months (T1)
|
The transition between the pink and white resin will be evaluated by means of a Visual Analogue Scale esthetic score Maximum (best outcome): 1000 Minimum (worst outcome): 0
|
3 months (T1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oral health-related quality of life
Time Frame: Baseline (BL, with existing dentures)
|
OHIP-EDENT: validated questionnaire with 19 questions related to 7 dimensions, by means of a 6-item Likert scale Maximum (worst outcome): 7 Minimum (best outcome: 0
|
Baseline (BL, with existing dentures)
|
|
Oral health-related quality of life
Time Frame: Day 0 (T0, new dentures)
|
OHIP-EDENT: validated questionnaire with 19 questions related to 7 dimensions, by means of a 6-item Likert scale Maximum (worst outcome): 7 Minimum (best outcome: 0
|
Day 0 (T0, new dentures)
|
|
Oral health-related quality of life
Time Frame: 3 months (T1)
|
OHIP-EDENT: validated questionnaire with 19 questions related to 7 dimensions, by means of a 6-item Likert scale Maximum (worst outcome): 7 Minimum (best outcome: 0
|
3 months (T1)
|
|
Denture satisfaction
Time Frame: Baseline (BL, with existing dentures)
|
Denture Satisfaction Index: validated questionnaire with 24 questions related to 9 dimensions, by means of a Visual Analogue Scale Maximum (best outcome): 900 Minimum (worst outcome): 0
|
Baseline (BL, with existing dentures)
|
|
Denture satisfaction
Time Frame: Day 0 (T0, new dentures)
|
Denture Satisfaction Index: validated questionnaire with 24 questions related to 9 dimensions, by means of a Visual Analogue Scale Maximum (best outcome): 900 Minimum (worst outcome): 0
|
Day 0 (T0, new dentures)
|
|
Denture satisfaction
Time Frame: 3 months (T1)
|
Denture Satisfaction Index: validated questionnaire with 24 questions related to 9 dimensions, by means of a Visual Analogue Scale Maximum (best outcome): 900 Minimum (worst outcome): 0
|
3 months (T1)
|
|
Masticatory analysis
Time Frame: Baseline (BL, with existing dentures)
|
Chewing efficiency will be evaluated with a two-color mixing ability test
|
Baseline (BL, with existing dentures)
|
|
Masticatory analysis
Time Frame: Day 0 (T0, new dentures)
|
Chewing efficiency will be evaluated with a two-color mixing ability test
|
Day 0 (T0, new dentures)
|
|
Masticatory analysis
Time Frame: 3 months (T1)
|
Chewing efficiency will be evaluated with a two-color mixing ability test
|
3 months (T1)
|
|
Prosthetic Evaluation
Time Frame: Day 0 (T0, new dentures)
|
Denture quality objectively based on the seven criteria adopted from Alfadda et al., 2014, using a scoring sheet with 16 questions, by means of a 3-item Likert scale Maximum (worst score): 48 Minimum (best score): 16
|
Day 0 (T0, new dentures)
|
|
Prosthetic Evaluation
Time Frame: 3 months (T1)
|
Denture quality objectively based on the seven criteria adopted from Alfadda et al., 2014, using a scoring sheet with 16 questions, by means of a 3-item Likert scale Maximum (worst score): 48 Minimum (best score): 16
|
3 months (T1)
|
|
Number of prosthetic maintenance needed
Time Frame: 3 months (T1)
|
events such as adjustment and repair requirements will be recorded
|
3 months (T1)
|
|
Willingness to Pay
Time Frame: 3 months (T1)
|
open-ended contingency valuation (CV) method of questioning with the use of a payment card. The score is the amount in Swiss Francs the participant would be willing to pay for the treatment. Maximum: no maximum Minimum: 0. |
3 months (T1)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sabrina Maniewicz, Dr, Research and Teaching Fellow
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Ivotion Pilot Study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Complete Edentulism
-
Nobel BiocareCompletedPartial Edentulism | Complete Edentulism
-
Nobel BiocareCompletedPartial Edentulism | Complete Edentulism
-
University of JordanCompleted
-
Badr UniversityCompleted
-
Rutgers, The State University of New JerseyNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Aldent UniversityCompletedComplete EdentulismAlbania
-
Cairo UniversityActive, not recruiting
-
Ain Shams UniversityCompletedComplete EdentulismEgypt
-
National Dental Centre, SingaporeNot yet recruitingComplete Edentulism
Clinical Trials on Ivoclar Ivotion Denture System
-
University of California, Los AngelesIvoclar Vivadent AGTerminated
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); ITI International Team for Implantology... and other collaboratorsActive, not recruitingEdentulous Mouth | Tooth-loss | Complete Denture | Complete Lower DentureCanada
-
University of MichiganIvoclar Vivadent AGTerminatedMissing ToothUnited States
-
University Hospital, MontpellierRecruitingDisorder of Maxillary and Mandibular Dental Arch RelationshipFrance
-
University Hospital, GhentSouthern Implants, South AfricaWithdrawn
-
Cairo UniversityCompleted
-
Cairo UniversityUnknown
-
Malmö UniversityActive, not recruitingDental Prosthesis FailureSweden
-
University of Concepcion, ChilePublic Health Service of ChileCompleted
-
University of Sao PauloUniversidade Federal de Sao CarlosCompleted